Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Phase 1b Study of MK-0482 in Adults with Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

    Not recruiting

    1 1 1
    Investigated Drugs:
    Spain
  • Study for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib

    Not recruiting

    2 1 1 1
    Italy Spain
  • Study on the Effectiveness and Safety of Ropeginterferon and Bosutinib for Patients with Chronic Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Denmark Finland Norway Sweden
  • Study of ponatinib and azacitidine combination treatment in patients with accelerated phase or blast crisis chronic myelogenous leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: Comparing Dasatinib, Imatinib, Nilotinib, and Bosutinib Strategies

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study of treatment discontinuation with nilotinib and asciminib in adults with chronic myeloid leukemia to achieve treatment-free remission

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Study on the Effectiveness of Asciminib and Imatinib for Patients with Chronic Myelogenous Leukemia Not Responding to Imatinib

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Austria Czechia France Italy Spain
  • Study of dose reduction strategy for tyrosine kinase inhibitors (imatinib, ponatinib, bosutinib, nilotinib, dasatinib) in patients with chronic myeloid leukemia

    Not recruiting

    3 1 1 1
    The Netherlands
  • Study of Ponatinib for Patients with Resistant Chronic Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Poland
  • Study of Bosutinib for Children with Newly Diagnosed or Resistant Chronic Myeloid Leukemia

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    France Germany Italy The Netherlands Spain